A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantationResearch in context

A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantationResearch in context

Summary: Background: Long-term treatment with immunosuppressants is necessary to attenuate allograft rejection following organ transplantation (OT). Consequently, the overall survival of OT recipients with malignancies has been substantially compromised by tumour recurrence. Rapamycin (RAPA) is a c...

Full description

Bibliographic Details
Main Authors: Zhentao Yang, Haiyang Xie, Jianqin Wan, Yuchen Wang, Liang Zhang, Ke Zhou, Hong Tang, Wentao Zhao, Hangxiang Wang, Penghong Song, Shusen Zheng
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:EBioMedicine
Subjects:
Organ transplantation
Hepatocellular carcinoma
Tumour recurrence
Nanotherapeutic strategy
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396423001597

Internet

http://www.sciencedirect.com/science/article/pii/S2352396423001597

Similar Items